NO944853D0 - Glukagonlignende peptid og insulinotropinderivater - Google Patents

Glukagonlignende peptid og insulinotropinderivater

Info

Publication number
NO944853D0
NO944853D0 NO944853A NO944853A NO944853D0 NO 944853 D0 NO944853 D0 NO 944853D0 NO 944853 A NO944853 A NO 944853A NO 944853 A NO944853 A NO 944853A NO 944853 D0 NO944853 D0 NO 944853D0
Authority
NO
Norway
Prior art keywords
glucagon
peptide
insulinotropin
derivatives
insulinotropin derivatives
Prior art date
Application number
NO944853A
Other languages
English (en)
Norwegian (no)
Other versions
NO944853L (no
Inventor
Glenn C Andrews
Gaston O Daumy
Michael L Francoeur
Eric R Larson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO944853D0 publication Critical patent/NO944853D0/no
Publication of NO944853L publication Critical patent/NO944853L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO944853A 1992-06-15 1994-12-14 Glukagonlignende peptid og insulinotropinderivater NO944853L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89907392A 1992-06-15 1992-06-15
PCT/US1993/003388 WO1993025579A1 (en) 1992-06-15 1993-04-14 Glucagon-like peptide and insulinotropin derivatives

Publications (2)

Publication Number Publication Date
NO944853D0 true NO944853D0 (no) 1994-12-14
NO944853L NO944853L (no) 1994-12-14

Family

ID=25410453

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944853A NO944853L (no) 1992-06-15 1994-12-14 Glukagonlignende peptid og insulinotropinderivater

Country Status (19)

Country Link
EP (2) EP0969016A2 (ja)
JP (1) JP2575298B2 (ja)
KR (1) KR0154880B1 (ja)
CN (1) CN1057098C (ja)
AU (1) AU671117B2 (ja)
BR (1) BR9306551A (ja)
CA (1) CA2138161C (ja)
CZ (1) CZ315594A3 (ja)
FI (1) FI932722A (ja)
HR (1) HRP930993A2 (ja)
HU (2) HUT64367A (ja)
IL (1) IL105928A0 (ja)
MX (1) MX9303554A (ja)
NO (1) NO944853L (ja)
PL (1) PL176007B1 (ja)
RU (1) RU2128663C1 (ja)
SK (1) SK155694A3 (ja)
WO (1) WO1993025579A1 (ja)
YU (1) YU41493A (ja)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849708B1 (en) 1986-05-05 2005-02-01 The General Hospital Corporation Insulinotropic hormone and uses thereof
US7138486B2 (en) 1986-05-05 2006-11-21 The General Hospital Corporation Insulinotropic hormone derivatives and uses thereof
US5614492A (en) * 1986-05-05 1997-03-25 The General Hospital Corporation Insulinotropic hormone GLP-1 (7-36) and uses thereof
US6284727B1 (en) 1993-04-07 2001-09-04 Scios, Inc. Prolonged delivery of peptides
US5705483A (en) 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
GB9409496D0 (en) * 1994-05-12 1994-06-29 London Health Ass Method for improving glycaemic control in diabetes
US5574008A (en) * 1994-08-30 1996-11-12 Eli Lilly And Company Biologically active fragments of glucagon-like insulinotropic peptide
US5512549A (en) * 1994-10-18 1996-04-30 Eli Lilly And Company Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
AU4415796A (en) * 1994-12-07 1996-06-26 Bionebraska, Inc. Production of c-terminal amidated peptides from recombinant protein constructs
US5834428A (en) 1995-04-14 1998-11-10 1149336 Ontario Inc. Glucagon-like peptide-2 and its therapeutic use
US6184201B1 (en) 1995-04-14 2001-02-06 Nps Allelix Corp. Intestinotrophic glucagon-like peptide-2 analogs
US5990077A (en) * 1995-04-14 1999-11-23 1149336 Ontario Inc. Glucagon-like peptide-2 and its therapeutic use
US5747453A (en) * 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
US6333189B1 (en) 1996-06-06 2001-12-25 Alza Corporation Method of making an electrotransport device
US6006753A (en) * 1996-08-30 1999-12-28 Eli Lilly And Company Use of GLP-1 or analogs to abolish catabolic changes after surgery
UA65549C2 (uk) 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
JP4798814B2 (ja) 1997-01-07 2011-10-19 アミリン・ファーマシューティカルズ，インコーポレイテッド 食物摂取低減用のエキセンジンおよびそのアゴニストの使用
JP2002510193A (ja) * 1997-03-31 2002-04-02 イーライ・リリー・アンド・カンパニー グルカゴン様ペプチド−１類似体
US7157555B1 (en) 1997-08-08 2007-01-02 Amylin Pharmaceuticals, Inc. Exendin agonist compounds
US7223725B1 (en) 1997-11-14 2007-05-29 Amylin Pharmaceuticals, Inc. Exendin agonist compounds
ATE381939T1 (de) 1997-11-14 2008-01-15 Amylin Pharmaceuticals Inc Neuartige exendin agonisten
US6380357B2 (en) 1997-12-16 2002-04-30 Eli Lilly And Company Glucagon-like peptide-1 crystals
FR2777283B1 (fr) * 1998-04-10 2000-11-24 Adir Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69941510D1 (de) 1998-08-10 2009-11-19 Us Gov Nat Inst Health Differenzierung von nicht-insulin in insulin-produzierende zellen durch glp-1 und exendin-4 und dessen verwendung
US7368427B1 (en) * 1998-12-07 2008-05-06 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas GLP-1 analogues
DE60006100T2 (de) 1999-05-17 2004-07-01 Conjuchem, Inc., Montreal Lang wirkende insulinotrope peptide
US6514500B1 (en) 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
EP2062593A3 (en) 2000-12-01 2011-08-17 Takeda Pharmaceutical Company Limited Method for producing preparation containing bioactive peptide
AU2002228608A1 (en) 2000-12-13 2002-06-24 Eli Lilly And Company Amidated glucagon-like peptide-1
EP2261250B1 (en) 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin fusion proteins
ES2614603T3 (es) 2002-02-20 2017-06-01 Emisphere Technologies, Inc. Procedimiento de administración de moléculas GLP-1
US20060286129A1 (en) 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
JP2007537149A (ja) * 2004-01-08 2007-12-20 セラテクノロジーズ インコーポレイテッド 長時間作用性のグルカゴン様ペプチド−１類似体
US8039432B2 (en) 2005-11-09 2011-10-18 Conjuchem, Llc Method of treatment of diabetes and/or obesity with reduced nausea side effect
EP2926825A1 (en) 2008-06-27 2015-10-07 Duke University Therapeutic agents comprising elastin-like peptides
WO2012006598A2 (en) 2010-07-09 2012-01-12 Dana-Farber Cancer Institute, Inc. Stabilized insulinotropic peptides and methods of use
US20150157619A1 (en) 2012-07-10 2015-06-11 Takeda Pharmaceutical Company Limited Pharmaceutical preparation for injection
US10639354B2 (en) 2015-05-22 2020-05-05 The Bot Of The Leland Stanford Junior University Treatment of hyperinsulinemic hypoglycemia with exendin (9-39)
US20190290772A1 (en) * 2016-06-02 2019-09-26 Indiana University Research And Technology Corporation Glucagon-like peptide-1-t3 conjugates
WO2018094404A1 (en) 2016-11-21 2018-05-24 Eiger Biopharmaceuticals, Inc. Buffered formulations of exendin (9-39)
PL3474820T3 (pl) 2017-08-24 2024-05-13 Novo Nordisk A/S Kompozycje glp-1 i ich zastosowania
EP4106724A1 (en) 2020-02-18 2022-12-28 Novo Nordisk A/S Glp-1 compositions and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04504246A (ja) * 1989-03-20 1992-07-30 ザ・ジェネラル・ホスピタル・コーポレーション インシュリン刺激ホルモン
JP3262329B2 (ja) * 1990-01-24 2002-03-04 アイ． バックレイ，ダグラス 糖尿病治療に有用なｇｌｐ―１アナログ
ES2087323T3 (es) * 1991-02-19 1996-07-16 Takeda Chemical Industries Ltd Metodo para producir peptidos exentos de cisteina.
DK36392D0 (da) * 1992-03-19 1992-03-19 Novo Nordisk As Anvendelse af kemisk forbindelse
DK36492D0 (da) * 1992-03-19 1992-03-19 Novo Nordisk As Praeparat
DK39892D0 (da) * 1992-03-25 1992-03-25 Bernard Thorens Peptid

Also Published As

Publication number Publication date
HRP930993A2 (en) 1996-12-31
IL105928A0 (en) 1993-10-20
YU41493A (sh) 1996-10-18
HUT64367A (en) 1993-12-28
AU4027593A (en) 1994-01-04
CA2138161A1 (en) 1993-12-23
HU9301739D0 (en) 1993-09-28
KR0154880B1 (ko) 1998-10-15
MX9303554A (es) 1994-06-30
EP0969016A2 (en) 2000-01-05
CN1057098C (zh) 2000-10-04
BR9306551A (pt) 1998-09-15
FI932722A (fi) 1993-12-16
NO944853L (no) 1994-12-14
JP2575298B2 (ja) 1997-01-22
CZ315594A3 (en) 1995-07-12
SK155694A3 (en) 1995-05-10
HU211498A9 (en) 1995-11-28
KR950701937A (ko) 1995-05-17
PL176007B1 (pl) 1999-03-31
AU671117B2 (en) 1996-08-15
WO1993025579A1 (en) 1993-12-23
JPH07504679A (ja) 1995-05-25
EP0646128A1 (en) 1995-04-05
CA2138161C (en) 2003-10-21
FI932722A0 (fi) 1993-06-14
RU94046251A (ru) 1996-10-27
CN1085913A (zh) 1994-04-27
RU2128663C1 (ru) 1999-04-10

Similar Documents

Publication Publication Date Title
NO944853D0 (no) Glukagonlignende peptid og insulinotropinderivater
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
DE59208263D1 (de) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate
NO921012L (no) Farmasoeytiske preparater og deres anvendelse
FI941398A (fi) Modifioituja peptidijohdannaisia
NO305952B1 (no) 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
EP0503301A3 (en) Peptide derivatives and application thereof
DE69221059D1 (de) Indolderivate und antiulcerose Zubereitungen
BR1100824A (pt) Composto e composição farmacêutica
NO924060D0 (no) Peg-imidater og proteinderivater derav
NO934878D0 (no) Herde-aktiverte sementblandinger og fremgangsmaater
IT1266582B1 (it) Derivati (di)azacicloesanici e diazacicloeptanici
DK6893D0 (da) Peptid
DE69220397D1 (de) Antimikrobielles Peptid und antimikrobieller Wirkstoff
DK0510912T3 (da) Antimikrobielt peptid og antimikrobielt middel
ITMI920408A1 (it) Derivati benzopiranici e benzotiopiranici
NO961274D0 (no) Azolderivat og farmasöytiske preparat derav
NO944838D0 (no) Arabinogalaktanderivater og anvendelser derav
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
NO922934D0 (no) Cykloheksan- og tetrahydropyranderivater
DK0456138T3 (da) Peptidamidaser og anvendelse deraf
ITMI931678A1 (it) Derivati benzossazinonici e benzotiazinonici terapeuticamente attivi
BR9205281A (pt) Pentapeptideos imuno-reguladores e neuro-reguladores
IL120890A (en) Glucagon-like peptide and insulinotropin derivatives
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application